![]() |
Volumn 3, Issue 1, 2014, Pages
|
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN II;
ATRIAL NATRIURETIC FACTOR;
CELL RECEPTOR;
CYCLIC GMP;
ENZYME ACTIVATOR;
GLYCERYL TRINITRATE;
GUANYLATE CYCLASE;
SOLUBLE GUANYLYL CYCLASE;
ANIMAL;
ARTERIAL PRESSURE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DISEASE MODEL;
DOG;
DRUG EFFECT;
ENZYME ACTIVATION;
ENZYMOLOGY;
HEART FAILURE;
HEART PACING;
HYPERTENSION;
KIDNEY CIRCULATION;
LUNG WEDGE PRESSURE;
MALE;
METABOLISM;
NATRIURESIS;
NATRIURETIC PEPTIDE;
PATHOPHYSIOLOGY;
TIME;
CYCLIC GMP;
HEART FAILURE;
HYPERTENSION;
NATRIURETIC PEPTIDE;
NITROGLYCERIN;
ALDOSTERONE;
ANGIOTENSIN II;
ANIMALS;
ARTERIAL PRESSURE;
ATRIAL NATRIURETIC FACTOR;
CARDIAC PACING, ARTIFICIAL;
DISEASE MODELS, ANIMAL;
DOGS;
ENZYME ACTIVATION;
ENZYME ACTIVATORS;
GUANYLATE CYCLASE;
HEART FAILURE;
HYPERTENSION;
MALE;
NATRIURESIS;
NITROGLYCERIN;
PULMONARY WEDGE PRESSURE;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RENAL CIRCULATION;
TIME FACTORS;
|
EID: 84898607051
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.113.000206 Document Type: Article |
Times cited : (28)
|
References (0)
|